Daniel Bazarko

Business address
C/O Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard, Boston, MA, 02210
Top holdings (ownership)
ALXN
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Daniel Bazarko has filed 16 SEC EDGAR filings since 19 Feb 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 23 Jul 2021 21 Jul 2021 000-27756
4 Open Document Open Filing FORM 4 16 Jul 2021 14 Jul 2021 000-27756
4 Open Document Open Filing FORM 4 02 Mar 2021 28 Feb 2021 000-27756
4 Open Document Open Filing FORM 4 21 Dec 2020 17 Dec 2020 000-27756
4 Open Document Open Filing FORM 4 18 Dec 2020 16 Dec 2020 000-27756
4 Open Document Open Filing FORM 4 03 Mar 2020 28 Feb 2020 000-27756
4 Open Document Open Filing FORM 4 02 Mar 2020 27 Feb 2020 000-27756
4 Open Document Open Filing FORM 4 10 Feb 2020 07 Feb 2020 000-27756
4 Open Document Open Filing FORM 4 04 Dec 2019 02 Dec 2019 000-27756
3/A Open Document Open Filing FORM 3/A 04 Dec 2019 19 Feb 2019 000-27756
4 Open Document Open Filing FORM 4 05 Mar 2019 28 Feb 2019 000-27756
4 Open Document Open Filing FORM 4 04 Mar 2019 28 Feb 2019 000-27756
4 Open Document Open Filing FORM 4 01 Mar 2019 27 Feb 2019 000-27756
4 Open Document Open Filing FORM 4 28 Feb 2019 26 Feb 2019 000-27756
4 Open Document Open Filing FORM 4 19 Feb 2019 14 Feb 2019 000-27756
3 Open Document Open Filing FORM 3 19 Feb 2019 19 Feb 2019 000-27756